filmov
tv
What is CAR T-cell therapy?
Показать описание
In this week's #AskDrDurie, multiple myeloma expert Dr. Brian G.M. Durie answers the question: What is CAR T-cell therapy and what patient population is this immunotherapy currently approved for?
The BOTTOM LINE:
CAR T-cell therapy is approved for patients with relapsed/refractory myeloma and who have had four or more prior lines of therapy. CAR T-cell therapy is in limited supply and only available in select specialized centers across the country.
_______________
Improving Lives | Finding the Cure
In the United States, an estimated 32,270 new multiple myeloma cases will be diagnosed in 2021. 159,985 new myeloma cases are diagnosed yearly.
Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.
Find us online:
Category
Nonprofits & Activism
License
Standard YouTube License
In most cases, captions are autogenerated by YouTube.
The BOTTOM LINE:
CAR T-cell therapy is approved for patients with relapsed/refractory myeloma and who have had four or more prior lines of therapy. CAR T-cell therapy is in limited supply and only available in select specialized centers across the country.
_______________
Improving Lives | Finding the Cure
In the United States, an estimated 32,270 new multiple myeloma cases will be diagnosed in 2021. 159,985 new myeloma cases are diagnosed yearly.
Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.
Find us online:
Category
Nonprofits & Activism
License
Standard YouTube License
In most cases, captions are autogenerated by YouTube.
0:06:13
Lymphoma: Overview of Chimeric Antigen Receptor (CAR) T cells
0:04:37
What is CAR T Cell Therapy?
0:02:21
CAR T-Cell Therapy: How Does It Work?
0:01:51
CAR T cell therapy for cancer treatment: How it works
0:18:33
CAR T-cell therapy: Reprogramming the immune system to treat cancer | Rob Weinkove | TEDxTauranga
0:04:16
CAR T-cell Therapy
0:01:32
CAR T Cell Therapy Explained (Animation) | City of Hope
0:58:59
CAR-T Cell Therapy: Current Uses and Future Possibilities
0:04:44
From Lymphoma to Recovery: Ms. Linda's CAR T-Cell Therapy Success at Artemis Hospitals
1:02:39
Update on CAR T-Cell Therapy | Lymphoma Research Foundation Webinars
0:55:10
CAR-T Cell Therapy: Now and in 2030 | Laboratory Medicine and Pathology in Individualized Medicine
0:00:46
How successful is CAR-T cell therapy?
0:59:27
Updates in CAR T Cell Therapies
0:09:41
CAR T-Cell Therapy | FAQ with Dr. Patrick Brown
0:01:42
CAR-T Cell Therapy Manufacturing Workflow
0:03:14
CAR T-cell Therapy explained (Manufacturing process & how it works)
0:01:21
CAR T Cell Therapy - How Does it work?
0:04:46
CAR T cell therapy: Overview
0:11:29
CAR T Cell Therapy Journey: Apheresis to Infusion
0:04:51
CAR-T Cell Therapy: Side-effects and neurotoxicity
0:03:26
Access to CAR T-Cell Therapy
0:02:00
What is CAR T-Cell Therapy?
0:01:32
Frontiers in Medicine: A Look at CAR T-Cell Therapy
1:01:59
Update on CAR T-Cell Therapy | LRF Webinars
Комментарии